Easier Access to Cancer Genetic Testing for Patients
This act aims to facilitate access to advanced genetic and laboratory tests for individuals diagnosed with cancer. It means Medicare, Medicaid, and CHIP will cover the costs of these tests, which can help in better treatment planning and disease monitoring, reducing financial burden for patients.
Key points
Medicare, Medicaid, and CHIP will cover advanced genetic and laboratory tests (like DNA sequencing) for cancer patients.
These tests will be covered upon diagnosis, recurrence, and for treatment planning or monitoring cancer progression.
The act includes an education program for physicians and the public on genomic testing and the role of genetic counselors.
Introduced
Citizen Poll